Adsorption therapy, such as CytoSorb (which target 5–60 kDa proteins), may theoretically be used to remove the myoglobin, inflammatory mediators, and other components triggered or transported within the wasp venom, but the high financial burden associated to this approach limits its used to treat wasp venom-induced AKI. The gene discussed is MB; the disease is acute kidney injury.